Renal-Limited Thrombotic Microangiopathy due to Bevacizumab Therapy for Metastatic Colorectal Cancer: A Case Report

Renal-Limited Thrombotic Microangiopathy due to Bevacizumab Therapy for Metastatic Colorectal Cancer: A Case Report

An 88-year-old Japanese man received bevacizumab for colorectal cancer with liver and peritoneal metastasis, during which nephrotic range proteinuria occurred (7.66 g/day). Renal biopsy showed endothelial damage with subendothelial swelling and a double contour of the glomerular basement membrane, w...

Full description

Bibliographic Details
Main Authors: Naoya Toriu, Akinari Sekine, Hiroki Mizuno, Eiko Hasegawa, Masayuki Yamanouchi, Rikako Hiramatsu, Noriko Hayami, Junichi Hoshino, Masahiro Kawada, Tatsuya Suwabe, Keiichi Sumida, Naoki Sawa, Kenmei Takaichi, Kenichi Ohashi, Takeshi Fujii, Shuichiro Matoba, Yoshifumi Ubara
Format: Article
Language:English
Published: Karger Publishers 2019-06-01
Series:Case Reports in Oncology
Subjects:
Thrombotic microangiopathy
Bevacizumab
Nephrotic syndrome
Colorectal cancer
Online Access:https://www.karger.com/Article/FullText/500716

Similar Items

Similar Items